http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Staff report on Sanofi's strategic use of third parties to influence the FDA
prepared by the staff of the Committee on Finance, United States Senate.
Title from title screen (viewed on July 21, 2011).
At head of title: 112th Congress, 1st session. Committee print.
Paper version available for sale by the Supt. of Docs., U.S. G.P.O.